Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Feb 18 04:00PM ET
154.99
Dollar change
-1.16
Percentage change
-0.74
%
IndexDJIA, S&P 500 P/E26.73 EPS (ttm)5.80 Insider Own0.17% Shs Outstand2.41B Perf Week0.49%
Market Cap373.16B Forward P/E13.99 EPS next Y11.08 Insider Trans-0.44% Shs Float2.40B Perf Month4.89%
Income14.07B PEG5.28 EPS next Q2.65 Inst Own72.99% Short Float0.78% Perf Quarter1.14%
Sales88.82B P/S4.20 EPS this Y6.08% Inst Trans0.76% Short Ratio2.15 Perf Half Y-2.58%
Book/sh29.70 P/B5.22 EPS next Y4.69% ROA8.09% Short Interest18.76M Perf Year-0.48%
Cash/sh10.19 P/C15.22 EPS next 5Y5.06% ROE20.06% 52W Range140.68 - 168.85 Perf YTD7.17%
Dividend Est.5.10 (3.29%) P/FCF18.81 EPS past 5Y0.55% ROI13.61% 52W High-8.21% Beta0.48
Dividend TTM4.96 (3.20%) Quick Ratio0.86 Sales past 5Y2.03% Gross Margin68.71% 52W Low10.17% ATR (14)2.40
Dividend Ex-DateFeb 18, 2025 Current Ratio1.11 EPS Y/Y TTM3.69% Oper. Margin23.52% RSI (14)58.79 Volatility1.40% 1.51%
Employees138100 Debt/Eq0.53 Sales Y/Y TTM-4.51% Profit Margin15.84% Recom2.17 Target Price168.94
Option/ShortYes / Yes LT Debt/Eq0.45 EPS Q/Q-15.14% Payout84.80% Rel Volume1.08 Prev Close156.15
Sales Surprise0.40% EPS Surprise2.43% Sales Q/Q5.27% EarningsJan 22 BMO Avg Volume8.71M Price154.99
SMA201.73% SMA504.46% SMA2000.53% Trades Volume9,393,296 Change-0.74%
Date Action Analyst Rating Change Price Target Change
Dec-10-24Resumed BofA Securities Neutral $166
Nov-15-24Initiated Wolfe Research Outperform $190
Jul-23-24Downgrade Daiwa Securities Outperform → Neutral $160 → $150
May-30-24Resumed Goldman Neutral $160
Apr-18-24Upgrade HSBC Securities Hold → Buy $170
Dec-13-23Downgrade Wells Fargo Overweight → Equal Weight $170 → $163
Dec-01-23Upgrade UBS Neutral → Buy $167 → $180
Oct-05-23Initiated RBC Capital Mkts Outperform $178
Sep-06-23Initiated HSBC Securities Hold $175
May-30-23Resumed Citigroup Buy $185
Today 02:40AM
Feb-18-25 05:22PM
10:23AM
06:05AM
05:00AM
06:37AM Loading…
Feb-17-25 06:37AM
02:54AM
Feb-15-25 01:00PM
12:28PM
Feb-14-25 11:35AM
08:00AM
Feb-13-25 12:31PM
08:30AM
08:05AM
07:30AM
06:31AM Loading…
06:31AM
Feb-12-25 10:37AM
09:18AM
07:11AM
Feb-11-25 02:27PM
06:02AM
Feb-09-25 05:30PM
12:30PM
07:15AM
Feb-08-25 04:40AM
Feb-07-25 09:00AM
Feb-06-25 05:07AM
01:08AM
Feb-05-25 09:59AM
09:06AM
06:01AM Loading…
Feb-04-25 06:01AM
Feb-03-25 04:30PM
08:02AM
04:30AM
03:50AM
Feb-02-25 02:23PM
12:21PM
Feb-01-25 08:34AM
07:30AM
06:14AM
03:34AM
Jan-31-25 05:12PM
02:23PM
Jan-30-25 12:18PM
Jan-29-25 10:29PM
02:04PM
09:27AM
05:00AM
Jan-28-25 01:11PM
11:45AM
09:40AM
07:35AM
06:12AM
06:01AM
12:19AM
Jan-27-25 01:52PM
09:00AM
Jan-25-25 11:05AM
10:50AM
06:17AM
Jan-24-25 07:14AM
04:51AM
02:01AM
Jan-23-25 04:57PM
03:40PM
02:01PM
12:42PM
12:30PM
11:45AM
08:08AM
08:00AM
07:31AM
05:35AM
05:08AM
02:02AM
01:01AM
Jan-22-25 08:28PM
04:41PM
04:33PM
04:32PM
03:52PM
02:16PM
02:00PM
01:44PM
12:54PM
12:48PM
12:03PM
11:32AM
11:15AM
10:22AM
09:36AM
09:30AM
09:09AM
08:25AM
08:21AM
07:34AM
07:30AM
06:29AM
06:23AM
06:20AM
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Schmid TimothyEVP, WW Chair, MedTechFeb 14 '25Option Exercise0.002,806017,904Feb 18 09:46 PM
Schmid TimothyEVP, WW Chair, MedTechFeb 15 '25Option Exercise0.001,029015,501Feb 18 09:33 PM
Schmid TimothyEVP, WW Chair, MedTechFeb 14 '25Option Exercise0.001,765015,111Feb 18 09:33 PM
Schmid TimothyEVP, WW Chair, MedTechFeb 13 '25Option Exercise0.00499013,539Feb 18 09:33 PM
Schmid TimothyEVP, WW Chair, MedTechFeb 18 '25Sale156.1540362,92815,098Feb 18 09:33 PM
Wengel Kathryn EEVP, Chief TO and Risk OfficerFeb 15 '25Option Exercise0.00607091,037Feb 18 09:16 PM
Wengel Kathryn EEVP, Chief TO and Risk OfficerFeb 14 '25Option Exercise0.007,367096,674Feb 18 09:16 PM
Wengel Kathryn EEVP, Chief TO and Risk OfficerFeb 13 '25Option Exercise0.00651089,603Feb 18 09:16 PM
Wolk Joseph JExec VP, CFOFeb 15 '25Option Exercise0.001,97106,113Feb 18 09:13 PM
Wolk Joseph JExec VP, CFOFeb 14 '25Option Exercise0.0019,330020,661Feb 18 09:13 PM
Wolk Joseph JExec VP, CFOFeb 13 '25Option Exercise0.001,77901,779Feb 18 09:13 PM
REED JOHN CEVP, Innovative Medicine, R&DFeb 15 '25Option Exercise0.001,350015,927Feb 18 09:11 PM
Taubert Jennifer LEVP, WWC. Innovative MedicineFeb 15 '25Option Exercise0.001,5940171,110Feb 18 09:08 PM
Taubert Jennifer LEVP, WWC. Innovative MedicineFeb 14 '25Option Exercise0.0019,5180185,924Feb 18 09:08 PM
Taubert Jennifer LEVP, WWC. Innovative MedicineFeb 13 '25Option Exercise0.001,3020167,221Feb 18 09:08 PM
Swanson James D.EVP, CIOFeb 15 '25Option Exercise0.00492016,762Feb 18 09:06 PM
Swanson James D.EVP, CIOFeb 14 '25Option Exercise0.005,079019,739Feb 18 09:06 PM
Swanson James D.EVP, CIOFeb 13 '25Option Exercise0.00447015,019Feb 18 09:06 PM
Mulholland KristenEVP, Chief HR OfficerFeb 15 '25Option Exercise0.00419013,095Feb 18 09:05 PM
Mulholland KristenEVP, Chief HR OfficerFeb 14 '25Option Exercise0.002,608014,576Feb 18 09:05 PM
Mulholland KristenEVP, Chief HR OfficerFeb 13 '25Option Exercise0.00411012,100Feb 18 09:05 PM
Forminard ElizabethExecutive VP, General CounselFeb 15 '25Option Exercise0.00961010,321Feb 18 09:03 PM
Forminard ElizabethExecutive VP, General CounselFeb 14 '25Option Exercise0.002,203011,366Feb 18 09:03 PM
Forminard ElizabethExecutive VP, General CounselFeb 13 '25Option Exercise0.0065108,991Feb 18 09:03 PM
Duato JoaquinCEO and Chairman of the BoardFeb 15 '25Option Exercise0.003,6820397,525Feb 18 09:02 PM
Duato JoaquinCEO and Chairman of the BoardFeb 14 '25Option Exercise0.0024,3350415,205Feb 18 09:02 PM
Duato JoaquinCEO and Chairman of the BoardFeb 13 '25Option Exercise0.003,4700392,498Feb 18 09:02 PM
Decker Robert JVP Corporate ControllerFeb 15 '25Option Exercise0.00339020,116Feb 18 09:01 PM
Decker Robert JVP Corporate ControllerFeb 14 '25Option Exercise0.002,201021,373Feb 18 09:01 PM
Decker Robert JVP Corporate ControllerFeb 13 '25Option Exercise0.00312019,285Feb 18 09:01 PM
Broadhurst VanessaEVP, Global Corp AffairsFeb 15 '25Option Exercise0.00492021,839Feb 18 08:58 PM
Broadhurst VanessaEVP, Global Corp AffairsFeb 14 '25Option Exercise0.004,740024,591Feb 18 08:58 PM
Broadhurst VanessaEVP, Global Corp AffairsFeb 13 '25Option Exercise0.00408020,242Feb 18 08:58 PM
Duato JoaquinCEO and Chairman of the BoardFeb 07 '25Option Exercise100.06126,36912,644,482489,671Feb 11 07:43 PM
Wengel Kathryn EEVP, Chief TO and Risk OfficerFeb 07 '25Option Exercise100.0632,7623,278,166115,028Feb 11 07:42 PM
Taubert Jennifer LEVP, WWC. Innovative MedicineFeb 07 '25Option Exercise100.0658,5045,853,910213,355Feb 11 07:41 PM
Wolk Joseph JExec VP, CFOFeb 07 '25Option Exercise100.0613,0151,302,28113,015Feb 11 07:40 PM
Wolk Joseph JExec VP, CFOFeb 07 '25Sale153.8913,0152,002,8780Feb 11 07:40 PM
Wolk Joseph JOfficerFeb 07 '25Proposed Sale153.8913,0152,002,924Feb 07 01:27 PM
WEINBERGER MARK ADirectorDec 12 '24Buy147.221,000147,2201,000Dec 12 05:27 PM
Hait WilliamFormer OfficerDec 04 '24Proposed Sale149.9025,7423,858,598Dec 04 01:25 PM
Decker Robert JVP Corporate ControllerAug 30 '24Option Exercise100.065,635563,83824,608Sep 03 04:48 PM
Decker Robert JVP Corporate ControllerAug 30 '24Sale165.065,635930,11318,973Sep 03 04:48 PM
Decker Robert JOfficerAug 30 '24Proposed Sale165.065,635930,113Aug 30 03:51 PM
Broadhurst VanessaEVP, Global Corp AffairsJul 08 '24Option Exercise0.009,809024,852Jul 09 05:48 PM
REED JOHN CEVP, Innovative Medicine, R&DMay 01 '24Option Exercise0.0022,255022,561May 03 04:31 PM
Broadhurst VanessaEVP, Global Corp AffairsMar 13 '24Sale162.168,8911,441,76515,043Mar 13 04:36 PM
JOHNSON & JOHNSON10% OwnerFeb 29 '24Option Exercise0.723,8552,7924,103,430Mar 06 03:42 PM